Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.
about
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticleStealth Properties to Improve Therapeutic Efficacy of Drug NanocarriersThe potential of polymeric micelles in the context of glioblastoma therapy.Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene deliveryStimuli-responsive nanomaterials for biomedical applicationsPolymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation.The influence of polymer topology on pharmacokinetics: differences between cyclic and linear PEGylated poly(acrylic acid) comb polymersSilk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumorsPolymeric nanomedicine for cancer MR imaging and drug deliveryEfficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.Enabling individualized therapy through nanotechnologyCold instability of aponeocarzinostatin and its stabilization by labile chromophore.Nanopharmaceuticals (part 1): products on the market.Current status of nanomedicine and nanosurgery.Block Ionomer Complex Micelles with Cross-Linked Cores for Drug Delivery.Procoagulant inhibitory properties of paclitaxel poliglumex.The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cellsAnticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy.Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters.A versatile technique for the in vivo imaging of human tumor xenografts using near-infrared fluorochrome-conjugated macromolecule probes.Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components.Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric NanomedicinesThe influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer.Polymeric nanogel formulations of nucleoside analogs.Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer.Paclitaxel poliglumex (PPX, CT-2103): macromolecular medicine for advanced non-small-cell lung cancer.Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.Tumor-targeted induction of oxystress for cancer therapy.Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate.Cancer therapies utilizing the camptothecins: a review of the in vivo literatureMultifunctional micellar nanomedicine for cancer therapy.Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.Macromolecules as taxane delivery systems.Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.Multifunctional dendritic polymers in nanomedicine: opportunities and challenges.Image-guided nanosystems for targeted delivery in cancer therapy.
P2860
Q24560011-94ADFB73-AB6D-48F1-BDF7-B5D4403AEB80Q27496024-092745C1-AAD4-4245-A627-32500FF09782Q27693205-8102DFBD-318F-4605-B304-2C9587154EEEQ28085438-DBC4D814-291E-4E12-AE1D-4A19A1DCA817Q30396768-FC189A14-9EE4-433C-9E0B-7FE25B0B9B2DQ33292829-95AF29BE-5DD2-4951-BCA1-A294E7E95D99Q33451490-8C5D6C26-C733-4835-B5B2-99075B872C6BQ33639168-E6394956-B106-4D5F-A779-E6C15874F162Q33773418-44C9A647-AED5-40C2-B0EA-CBC8EE4343F2Q33913718-D80717C5-9ECA-46C3-B899-4B1156D17DE8Q33917755-9695C90A-F299-4171-82AE-8E96563A92E4Q34190719-F99C4CCB-7805-48BB-A41F-B3285DA44EDDQ34230175-A347CE70-2081-4284-A38A-23BF80AE6962Q34236861-B3046EA5-D666-48ED-8977-A2CA88586BB8Q34364190-DC27B7F6-42B7-4F99-B3EB-198B8E3BEBD4Q34665903-78764FDE-15CD-4D10-B09F-7051BEAC134FQ34946461-27493935-0FA5-4942-85FC-2735E9EE6243Q34984769-C84CA71E-1CCA-4FFC-BECA-3D271C969724Q34989252-07B32ECB-047F-4A36-A706-A4F8AA4EFE6EQ35072877-E94F2926-0C4F-40E8-8433-EA6F9CD39D90Q35375097-25C51F66-9C5F-4DE2-8F01-16F260F54E20Q35459059-75AA34B1-D0C3-4305-80DE-3AA405BDEFA8Q35861726-DB888DCD-D75C-43A8-95E7-142DD807FAC0Q36129610-9D515E2C-ED64-4583-87FF-4302B8A3B7A8Q36667452-EA2C4F4A-B47A-45F9-8A35-5F1F242E70F2Q36668023-A8BD13FE-06FD-4E4D-8DF4-7E2F45BCCD99Q36672633-FE84DF7B-2CD0-4ED8-8BF3-1EFA030131C0Q36788450-5092E5AA-8BB5-4AF0-8B09-7876C7FAF5FCQ36900208-3457ACAE-A4C1-4D97-9D85-3113022F1FC5Q36900213-1B2F0CA5-558B-43AF-9B8E-B8BDB71D8D5EQ36920312-2A65DCD1-DED7-48E6-8294-D68DB8169ED0Q37069556-2D2F193E-673E-4B61-BB6D-BF0C35A35DEDQ37344163-B642D942-39BF-4348-B1EE-E62BB43802B6Q37419563-0592A4E1-71B2-468E-B7C3-028929255B3AQ37599474-9D0CDCF6-C831-434E-BCD8-7E4F19E94850Q37668347-F60C525A-EE70-4CBE-B877-CCCCC10BCC6EQ37818236-4CA3776D-CAEE-4C47-9C63-C7B2BBC691FEQ37886750-F7C33291-F9B2-46C9-BB30-36E190B9DDDDQ37967150-1805A134-562D-453E-8C36-25BD4DB60862Q38011794-1FB02AB3-B7EF-4BF2-B6C7-4464E835070E
P2860
Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Macromolecular therapeutics: a ...... sis on solid tumour targeting.
@ast
Macromolecular therapeutics: a ...... sis on solid tumour targeting.
@en
type
label
Macromolecular therapeutics: a ...... sis on solid tumour targeting.
@ast
Macromolecular therapeutics: a ...... sis on solid tumour targeting.
@en
prefLabel
Macromolecular therapeutics: a ...... sis on solid tumour targeting.
@ast
Macromolecular therapeutics: a ...... sis on solid tumour targeting.
@en
P2093
P1476
Macromolecular therapeutics: a ...... sis on solid tumour targeting.
@en
P2093
Akinori Nagamitsu
Hiroshi Maeda
Khaled Greish
Takao Inutsuka
P304
P356
10.2165/00003088-200342130-00002
P577
2003-01-01T00:00:00Z
P6179
1027613734